9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Estimated reading time: 1 min

Condition: Mesothelioma

Estimated Enrollment: 240

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: The primary objective of this study is to compare the overall survival following treatment with Pemetrexed plus best supportive care versus best supportive care alone,  To characterize and compare the toxicities of Pemetrexed/best supportive care and best supportive care alone in this patient population;to determine the objective-tumor response rate,  to compare time to event efficacy variables of both arms including:duration of response,time to objective tumor response,time to treatment failure,time to documented disease progression,progression-free survival, to compare changes in the average symptom burden index between the Pemetrexed/best supportive care and best supportive care arms

Interventions: Pemetrexed,

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date:

Completion Date: November 2005

Last  Posted Date: January 26, 2007

Location: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM – 5:00 PM Eastern Time (UTC/GMT – 5 hrs, EST), or speak with your personal physician, Ottawa, Ontario, Canada

Website Link: https://ClinicalTrials.gov/show/NCT00190762

Was this article helpful?
Dislike 0